Drug profile · INN
solriamfetol hydrochloride
SUNOSI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
solriamfetol hydrochloride (SUNOSI) is an FDA-listed pharmaceutical active ingredient. Associated with Axsome Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN solriamfetol hydrochloride
Brand SUNOSI
Route ORAL
Formulation TABLET
Originator Axsome Therapeutics
Frequently asked questions
What is solriamfetol hydrochloride?
solriamfetol hydrochloride (SUNOSI) is an FDA-listed pharmaceutical active ingredient. Associated with Axsome Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for solriamfetol hydrochloride?
SUNOSI is a marketed brand name for solriamfetol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of solriamfetol hydrochloride?
solriamfetol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.